USPTO serial 90732485
PSYENCE
Reviewed by CopyMark Law Group
Status 734Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROWNING, KATHRYN ELISABETH
- Law office
- TMO LAW OFFICE 124
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PSYENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $996*
Plus Government fees of $500
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Toronto, Ontario, CA
TORONOTO, CA
Toronto, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy J Benjamin
Amy J Benjamin BENJAMIN LAW PC111 EAST 14TH STREETSUITE 469NEW YORK, NY 10003Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-epileptic pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the relief of pain; preparations for the treatment of mental health disorders; pharmaceutical preparations and herbal supplements for enhancing mental health; pharmaceutical preparations, namely cognitive enhancers for the treatment of mental health disorders; herbal supplements, namely cognitive enhancers; dietary supplements for enhancing mental health, and for the treatment of mental health disorders; dietary and nutritional supplements for alleviating symptoms experienced in the palliative care setting, namely, nausea, anorexia, cachexia, severe intractable pain, severe depressed mood, and insomnia; plant-based supplements for aiding general health, well-being and cognitive function | ACTIVE | — |
| 029 | Dried edible fungi; dried edible mushrooms; dried edible mushrooms; edible fungi oils not containing psilocybin or psilocin, fungal extracts for use as ingredients of nutritional supplements; fruit jellies not being confectionary | ACTIVE | — |
| 031 | Fresh edible fungi; fresh edible mushrooms; fresh mushrooms; unprocessed mushrooms | ACTIVE | — |
| 042 | Research and development in the fields of neurological conditions and their treatment and psychological conditions and their treatment; basic and clinical research in the fields of plant-based medicines and psychedelics; research and development in the field of holistic medicines, natural medicine, psychedelics and nootropics; research and development of treatments for mental health conditions; pharmaceutical research and development in the field of psilocybin; research and development in the field of psilocybin, holistic medicines, natural medicine, psychedelics and nootropics; research and development of psilocybin-based treatments for mental health conditions; scientific research in the nature of conducting clinical trials for others in the field of medicine and mental health; providing scientific research information in the field of psilocybin, psychoactive products, psychedelics and nootropics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Psyence Biomed Corp.
- Other trademarks owned by Psyence Group Inc.
- Other trademarks owned by Psyence Biomed Corp.
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 031
- Other trademarks in Class 042
- Similar marks named PSYENCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | PILM | PETITION INQUIRY LETTER ISSUED | — |
| Nov 2, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 28, 2026 | PCRC | PETITION TO DIRECTOR RECEIVED | — |
| Apr 28, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Nov 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 12, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 8, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 7, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 6, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 5, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 5, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 6, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 6, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 11, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 11, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 30, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 30, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 30, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 9, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Sep 9, 2024 | PGEX | PETITION GRANTED - EXTENSION REQUEST FILED | — |
| Aug 22, 2024 | ERTP | TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED | — |
| Jul 31, 2024 | PINM | INCOMPLETE PETITION NOTICE MAILED | — |
| Jun 20, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 7, 2024 | ERTP | TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED | — |
| May 14, 2024 | PINM | INCOMPLETE PETITION NOTICE MAILED | — |
| May 13, 2024 | APET | ASSIGNED TO PETITION STAFF | — |
| May 9, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 9, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 13, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Feb 12, 2024 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Feb 12, 2024 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Feb 12, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 12, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 11, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 11, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 9, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 4, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 22, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 9, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 10, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 16, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 1, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 21, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 28, 2021 | NWAP | NEW APPLICATION ENTERED | — |